Envestnet Asset Management Inc Cara Therapeutics, Inc. Transaction History

Envestnet Asset Management Inc

  • $302 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$0.52 - $1.05 $18,611 - $37,580
35,791 New
35,791 $32,000
Q3 2022

Nov 10, 2022
SELL
$8.24 - $12.56 $44,355 - $67,610
-5,383 Reduced 32.05%
11,413 $107,000
Q2 2022

Aug 03, 2022
SELL
$7.45 - $13.84 $31,640 - $58,778
-4,247 Reduced 20.18%
16,796 $153,000
Q1 2022

May 04, 2022
BUY
$9.94 - $12.65 $209,167 - $266,193
21,043 New
21,043 $256,000

Others Institutions Holding CARA

# of Institutions
64
Shares Held
12.7M
Call Options Held
0
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $257M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email